Standout Papers

A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate ... 2001 2026 2009 2017 566
  1. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD (2001)
    Bengt Winblad, Knut Engedal et al. Neurology

Immediate Impact

5 from Science/Nature 67 standout
Sub-graph 1 of 22

Citing Papers

Donanemab in Early Alzheimer’s Disease
2021 Standout
Prevention of Falls in Community-Dwelling Older Adults
2020 Standout
2 intermediate papers

Works of Ponni Subbiah being referenced

A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer’s disease
2001
A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD
2001 Standout

Author Peers

Author Last Decade Papers Cites
Ponni Subbiah 1013 738 414 18 1.6k
Anders Haglund 666 499 302 18 1.2k
Jane Hecker 777 562 430 31 1.6k
I. Gergel 922 932 377 28 2.2k
Sharon L. Rogers 704 677 370 8 1.5k
Paul Kershaw 627 686 354 13 1.3k
J. Michael Ryan 946 342 716 29 2.0k
John R. Ieni 920 877 575 35 2.2k
C. Beck 994 213 560 10 1.6k
Jean Georges 1071 200 495 52 2.2k
Richard D. Hartman 536 560 423 62 1.9k

All Works

Loading papers...

Rankless by CCL
2026